Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
Go back to Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 15.97 +0.65 (4.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.32 | 52 Week High | $0.19 | |||
| Open | $15.47 | 52 Week Low | $0.07 | |||
| Day High | $16.10 | P/E | N/A | |||
| Day Low | $15.33 | EPS | $-0.01 | |||
| Volume | 1,921,591 | |||||
